Cited by 56Alzheimer's disease research and treatmentsCalcium signaling and nucleotide metabolismNeuroscience and Neuropharmacology Research

Sex-dependent calcium hyperactivity due to lysosomal-related dysfunction in astrocytes from APOE4 versus APOE3 gene targeted replacement mice

Open access
Larramona-Arcas, Raquel, González-Arias, Candela, Perea, Gertrudis, Gutiérrez, Antonia, Vitorica, Javier, García-Barrera, Tamara, Gómez-Ariza, José Luis, Pascua-Maestro, Raquel +7 more·2020·Molecular Neurodegeneration

Abstract

Background: The apolipoprotein E (APOE) gene exists in three isoforms in humans: APOE2, APOE3 and APOE4. APOE4 causes structural and functional alterations in normal brains, and is the strongest genetic risk factor of the sporadic form of Alzheimer’s disease (LOAD). Research on APOE4 has mainly focused on the neuronal damage caused by defective cholesterol transport and exacerbated amyloid-β and Tau pathology. The impact of APOE4 on non-neuronal cell functions has been overlooked. Astrocytes, the main producers of ApoE in the healthy brain, are building blocks of neural circuits, and Ca 2+ signaling is the basis of their excitability. Because APOE4 modifies membrane-lipid composition, and lipids regulate Ca 2+ channels, we determined whether APOE4 dysregulates Ca 2+signaling in astrocytes. Methods: Ca 2+ signals were recorded in astrocytes in hippocampal slices from APOE3 and APOE4 gene targeted replacement male and female mice using Ca 2+ imaging. Mechanistic analyses were performed in immortalized astrocytes. Ca 2+ fluxes were examined with pharmacological tools and Ca 2+ probes. APOE3 and APOE4 expression was manipulated with GFP-APOE vectors and APOE siRNA. Lipidomics of lysosomal and whole-membranes were also performed. Results: We found potentiation of ATP-elicited Ca 2+responses in APOE4 versus APOE3 astrocytes in male, but not female, mice. The immortalized astrocytes modeled the male response, and showed that Ca 2+ hyperactivity associated with APOE4 is caused by dysregulation of Ca 2+ handling in lysosomal-enriched acidic stores, and is reversed by the expression of APOE3, but not of APOE4, pointing to loss of function due to APOE4 malfunction. Moreover, immortalized APOE4 astrocytes are refractory to control of Ca 2+ fluxes by extracellular lipids, and present distinct lipid composition in lysosomal and plasma membranes. Conclusions: Immortalized APOE4 versus APOE3 astrocytes present: increased Ca 2+ excitability due to lysosome dysregulation, altered membrane lipidomes and intracellular cholesterol distribution, and impaired modulation of Ca 2+ responses upon changes in extracellular lipids. Ca 2+ hyperactivity associated with APOE4 is found in astrocytes from male, but not female, targeted replacement mice. The study suggests that, independently of Aβ and Tau pathologies, altered astrocyte excitability might contribute to neural-circuit hyperactivity depending on APOE allele, sex and lipids, and supports lysosome-targeted therapies to rescue APOE4 phenotypes in LOAD.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s13024-020-00382-8

Cites

113 of 113 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Ca hyperactivity associated with ApoE4 is found in astrocytes from targeted replacement mice.

    “Ca hyperactivity associated with ApoE4 is found in astrocytes from targeted replacement mice [52].”

    From APOE4 genotype exacerbates the depression-like behavior of mice during aging through ATP decline (2021) · cites this paper as [52]

    The Discussion reports Ca2+ hyperactivity in astrocytes from APOE4 targeted replacement male mice, but not females. The claim omits that sex-specific limitation. (LLM, conf=0.87)

    Experimental — accuracy not yet measured
  • Astrocytes expressing ApoE4 exhibit higher cytosolic levels of Ca2+, mainly through ER IP3R-mediated release.

    “astrocytes expressing ApoE4 exhibit higher cytosolic levels of Ca2+, mainly through ER inositol 1,4,5-trisphosphate receptor (IP3R)-mediated release [57].”

    From Apoe4 and Alzheimer’s Disease Pathogenesis—Mitochondrial Deregulation and Targeted Therapeutic Strategies (2023) · cites this paper as [57]

    The Results report greater stimulus-evoked cytosolic Ca2+ responses in APOE4 than APOE3 astrocytes, but not generally higher resting levels; another Results passage reports lower basal Ca2+ in APOE4 cells. The proposed main mechanism is also wrong: the Results say ER release is only slightly increased and cannot alone explain the larger responses, while the Discussion identifies increased release from acidic stores as the key difference (pages not available in our copy). (LLM, conf=0.90)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Larramona-Arcas, R., González-Arias, C., Perea, G., Gutiérrez, A., Vitorica, J., García-Barrera, T., Gómez-Ariza, J. L., Pascua-Maestro, R., Ganfornina, M. D., Kara, E., Hudry, E., Martinez-Vicente, M., Vila, M., Galea, E., & Masgrau, R.
Affiliations
  • Consejo Superior de Investigaciones Científicas (ES)
  • Biomedical Research Networking Center on Neurodegenerative Diseases (ES)
  • Universidad de Valladolid (ES)
  • Harvard University (US)
  • Institució Catalana de Recerca i Estudis Avançats (ES)
  • Universitat Autònoma de Barcelona (ES)
Corresponding author
Masgrau, Roser
Venue
Molecular Neurodegeneration
Published
2020-06-09
Volume
15
Issue
1
Pages
35-35
ISSN
1750-1326 (ISSN-L)
OpenAlex
W3034140617
Cited by
56
References
113
Citations by year
2026: 7 · 2025: 9 · 2024: 7 · 2023: 10 · 2022: 11 · 2021: 11 · 2020: 1
FWCI
4.81
Type
journal article
Language
en
Open access
Locations
  • Molecular Neurodegeneration (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (publishedVersion, cc-by-nc-nd)
  • RISalud Institutional Health Repository of Andalucía (submittedVersion, cc-by)
  • Dipòsit Digital de Documents de la UAB (Universitat Autònoma de Barcelona) (submittedVersion, cc-by)
  • Repositorio Institucional de la Universidad de Huelva (Universidad de Huelva) (submittedVersion)
  • DIGITAL.CSIC (Spanish National Research Council (CSIC)) (submittedVersion, cc-by)
  • LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Hispana (submittedVersion, cc-by-nc-nd)
  • idUS (Universidad de Sevilla) (submittedVersion, cc-by-nc-nd)
  • Repositorio Institucional de la Universidad de Huelva (Universidad de Huelva) (submittedVersion, cc-by-nc-nd)
  • RECERCAT (Consorci de Serveis Universitaris de Catalunya) (submittedVersion, other-oa)
Funders
  • Agència de Gestió d’Ajuts Universitaris i de Recerca (2017 SGR1780, 2017 SGR547)
  • Ministerio de Economía, Industria y Competitividad, Gobierno de España (BES-2017-080303, BFU2016-75107-P)
  • Fundació la Marató de TV3 (TV3-20141430, TV3-20141432, TV3-20141431)
  • Ministerio de Ciencia e Innovación (BFU2015-68149-R)
  • Instituto de Salud Carlos III (PI18/01557)
Topics
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Physiology › Calcium signaling and nucleotide metabolism
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
Keywords
APOE ε4, astrocytes, calcium signaling, lysosomal dysfunction, sex differences, Alzheimer's disease, cholesterol distribution, extracellular lipids, calcium flux, hippocampus, intracellular calcium stores
MeSH terms
Alzheimer Disease, Animals, Astrocytes, Calcium, Cholesterol, Female, Hippocampus, Lysosomes, Male, Mice, Transgenic, Neurons, Apolipoprotein E3, Apolipoprotein E4

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review